IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Krensavage Asset Management, LLC

Q3 2025 Holdings

Filed 2025-11-17 | 17 holdings | $31.4M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Biomarin Pharmaceutical Inc(BMRN)COM09061G101$22.0M405,45070.0%
Biontech SE(BNTX)COM09075V102$7.8M79,36624.9%
Biogen Inc(BIIB)COM09062X103$1.4M10,0004.5%
United Therapeutics Corp(UTHR)COM91307C102$40.9K97,6460.1%
Enanta Pharmaceuticals Inc(ENTA)COM29251M106$25.3K2,114,4440.1%
Jazz Pharmaceuticals PLC(JAZZ)COMG50871105$22.1K167,8160.1%
Exelixis Inc(EXEL)COM30161Q104$21.4K518,5260.1%
Supernus Pharmaceuticals Inc(SUPN)COM868459108$17.4K363,4790.1%
Sanofi(SNY)COM80105N105$15.3K323,9460.0%
Avadel PharmaceuticalsCOMG29687103$14.6K955,8600.0%
GSK PLC(GSK)COM37733W204$11.7K271,7290.0%
Cardinal Health Inc(CAH)COM14149Y108$11.6K73,7450.0%
Indivior PLC(INDV)COMG4766E116$8.2K339,5320.0%
Alkermes PLC(ALKS)COMG01767105$6.2K207,8220.0%
Vanda Pharmaceuticals Inc(VNDA)COM921659108$5.9K1,180,3880.0%
Regeneron Pharmaceuticals(REGN)COM75886F107$2.2K4,0000.0%
Evolus Inc(EOLS)COM30052C107$614100,0000.0%